23 October 2014
Following the success of the one day "Designing Safer Medicines" meeting in 2011, a fresh line up of experts was assembled for the "Designing Safer Medicines: What works and what doesn't" conference took place at SCI in London on Monday 13th October.
This event ran back to back with "Highlights in Medicinal Chemistry" which took place the following day.Available conference papers
- Reducing cardiovascular safety-related attrition: the good, the bad, the ugly and the future - Dr Chris Pollard, AstraZeneca
- Designing in safer chemistry space: the use of multiparametric models in predicting drug safety - Dr Nigel Greene, Pfizer Worldwide Medicinal Chemistry
- Early safety evaluation: combining polypharmacology predictions and network biology to prioritize experimental testing - Dr Cedric Merlot, LeadOp Computing